INNOVEXX est une usine d'extraction végétale dédiée à la transformation de l'artemisia à Madagascar.
| Website | http://www.bionexx.com |
| Revenue | $41.5 million |
| Employees | 9 (9 on RocketReach) |
| Founded | 2005 |
| Phone | +261 32 05 020 06 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Pharmaceuticals, Manufacturing |
| Keywords | Plant Extraction, Botanical Extraction, Herbal Extracts, Botanical Extracts, Herbal Processing, Essential Oils, Natural Ingredients, Plant Based Materials, Natural Product Manufacturing, Quality Ingredients, Plant Derived Ingredients, Ingredient Supplier, Agricultural Processing, Plant Based Products, Sustainable Sourcing, Bulk Ingredients, Supply Chain |
| Competitors | Johnson & Johnson, Roche, Thermo Fisher Scientific, AbbVie, Merck & Co., Inc., Pfizer, GSK, AstraZeneca, Bristol Myers Squibb, Amgen +44 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular INNOVEXX employee's phone or email?
INNOVEXX Questions
The INNOVEXX annual revenue was $41.5 million in 2026.
Charles Giblain is the CEO of INNOVEXX.
9 people are employed at INNOVEXX.
INNOVEXX is based in Antananarivo, Analamanga.
The NAICS codes for INNOVEXX are [325, 32541, 3254, 32].
The SIC codes for INNOVEXX are [283, 28].
Top INNOVEXX Employees
Related Companies
G2Crowd Trusted
300K+
Plugin Users
